Screening for Incidental Coronary Calcification on Abdominal CT: Clinical Implications and Evidence-Based Recommendations

Abstract

Coronary artery calcification (CAC) is a well-established marker of subclinical atherosclerosis and cardiovascular risk. While CAC is most commonly identified on dedicated cardiac imaging, incidental detection on non-gated abdominal computed tomography (CT) scans is increasingly recognized due to the rising use of cross-sectional imaging for non-cardiac indications. This review synthesizes current evidence regarding the epidemiology, pathophysiology, risk factors, and clinical significance of incidental CAC on abdominal CT. Emphasis is placed on diagnostic considerations, management strategies, guideline recommendations, and the practical implications of reporting incidental CAC findings to improve cardiovascular risk stratification and patient outcomes.

Introduction

The incidental identification of coronary calcification on abdominal CT scans represents an emerging opportunity for cardiovascular risk assessment in patients undergoing imaging for non-cardiac indications. With the increasing utilization of abdominal CT in clinical practice, radiologists and clinicians are more frequently encountering coronary artery calcifications not initially sought for evaluation. The clinical challenge lies in determining the significance of these findings and integrating them into comprehensive patient care. This review explores the scientific and clinical aspects of incidental CAC on abdominal CT, evaluates its predictive value for cardiovascular events, and discusses the implications for risk modification and management.

Epidemiology / Disease Burden

Incidental CAC is detected in a significant proportion of adults undergoing abdominal CT, particularly in older populations or those with traditional cardiovascular risk factors. Large retrospective studies suggest a prevalence of incidental CAC ranging from 10% to 30% in abdominal CT cohorts, depending on age, sex, and underlying comorbidities. The Global Burden of Cardiovascular Diseases underscores the importance of early detection and risk stratification, as atherosclerotic disease remains the leading cause of mortality worldwide. Notably, the presence of CAC, even when incidentally discovered, is associated with an increased risk of major adverse cardiovascular events (MACE) independent of traditional risk assessment tools.

Pathophysiology

Coronary artery calcification represents the late-stage manifestation of atherosclerotic plaque development. The process involves the deposition of calcium hydroxyapatite within the intimal and medial layers of coronary arteries, promoted by chronic inflammation, lipid accumulation, endothelial dysfunction, and vascular smooth muscle cell transformation. Incidental CAC identified on abdominal CT reflects underlying subclinical atherosclerosis and systemic vascular pathology. The spatial distribution and extent of calcification correlate with overall plaque burden and risk of plaque rupture, providing mechanistic insights into its prognostic value for cardiovascular events.

Risk Factors

Traditional cardiovascular risk factors such as advanced age, male sex, hypertension, diabetes mellitus, dyslipidemia, smoking, chronic kidney disease, and family history of premature coronary artery disease are strongly associated with the development and progression of coronary calcification. Non-traditional factors, including chronic inflammatory states, metabolic syndrome, and certain genetic predispositions, also contribute to pathogenesis. The incidental detection of CAC on abdominal CT warrants careful assessment of these risk factors, as their presence may amplify the prognostic significance of the imaging finding.

Clinical Features

Patients with incidental CAC on abdominal CT are often asymptomatic and undergo imaging for unrelated indications, such as evaluation of abdominal pain, malignancy staging, or trauma. The absence of cardiac symptoms does not mitigate the prognostic implications of the finding. In some cases, the presence of CAC may prompt further evaluation for subclinical coronary artery disease, especially in patients with multiple risk factors. It is essential for clinicians to recognize the silent nature of atherosclerosis and the potential for CAC to serve as an early warning sign of increased cardiovascular risk.

Diagnosis

While dedicated, ECG-gated cardiac CT is the gold standard for quantitative CAC scoring (Agatston score), non-gated abdominal CT can reliably identify moderate to severe coronary calcification. The sensitivity of visual detection is influenced by slice thickness, motion artifact, and the inclusion of the heart within the scan field. Several studies have validated the reproducibility of visual CAC assessment on abdominal CT, with high interobserver agreement. Reporting systems such as the Coronary Artery Calcium Data and Reporting System (CAC-DRS) provide standardized frameworks for describing and communicating incidental CAC findings, improving clinical utility and follow-up consistency.

Treatment & Management

The management of patients with incidentally detected CAC on abdominal CT should be individualized based on overall cardiovascular risk assessment. For patients without known atherosclerotic cardiovascular disease (ASCVD), the presence of CAC may warrant intensification of lifestyle modification, optimization of blood pressure, lipid, and glycemic control, as well as consideration for statin therapy in accordance with current prevention guidelines. Shared decision-making is critical, as the psychological impact and downstream testing must be balanced against potential benefits. In selected cases, referral for further cardiac evaluation, including functional testing or dedicated CAC scoring, may be appropriate.

Recent Advances / Emerging Therapies

Recent research has focused on refining the prognostic value of incidental CAC and integrating artificial intelligence (AI)-based algorithms for automated detection and quantification on non-cardiac CT scans. Studies suggest that leveraging these technologies can improve identification rates, reduce interobserver variability, and facilitate large-scale cardiovascular risk stratification. Furthermore, there is growing interest in the use of novel biomarkers, imaging modalities, and pharmacologic agents targeting vascular calcification pathways, although their clinical applicability in the context of incidental CAC remains under investigation.

Guideline Recommendations

Professional societies such as the American College of Radiology (ACR), Society of Cardiovascular Computed Tomography (SCCT), and European Society of Cardiology (ESC) advocate for the routine reporting of incidental CAC when identified on non-cardiac CT scans. Guidelines emphasize the need for standardized terminology, communication to referring providers, and integration of findings into risk assessment algorithms. Current recommendations support the use of CAC presence as a risk-enhancing factor to guide preventive interventions, particularly in individuals at intermediate cardiovascular risk. However, routine downstream cardiac imaging solely for incidental CAC is not universally endorsed and should be tailored to clinical context.

Conclusion

Incidental coronary calcification detected on abdominal CT represents a valuable, underutilized marker for cardiovascular risk stratification. Its identification offers clinicians an opportunity to re-evaluate and optimize preventive strategies in patients who may otherwise remain unrecognized for elevated cardiovascular risk. Standardized reporting, multidisciplinary communication, and evidence-based management are essential to harness the prognostic potential of incidental CAC. Ongoing research and emerging technologies hold promise for further enhancing the clinical utility and integration of these findings into routine patient care.